Fourthly, other cancer cell lines and/or normal cell lines should be used and other biomarkers, for example, nuclear factor erythroid 2-related factor 2 (NRF2) and p53, should be determined in the present study as well. The gene discussed is NFE2L2; the disease is cancer.